Skip to main content
Log in

Estrogen Receptor Content in Malignant Breast Tumors in Men—a Review

  • Published:
Journal of Mammary Gland Biology and Neoplasia Aims and scope Submit manuscript

Abstract

Male breast cancer is a rare disease and clinical or epidemiological data are available from only a relatively few cases. Nonetheless, both similarities and discrepancies are apparent between breast cancer in men and women. For example, lobular and mucinous carcinomas are seldom seen in men. Tumors in men more often display neuroendocrine differentiation, with an average age at diagnosis ten years later than in women. A high proportion of breast tumors in men are estrogen receptor-α positive (in this review 77%) and progesterone receptor positive (76%). Breast tumors in men often respond favorably to endocrine manipulation, including testicular ablation or antiestrogen therapy. Thus, the hormone receptors in these tumors can be functionally active and used for therapeutic intervention. This proposal has been questioned in some studies because estrogen dependent proteins are expressed to a lesser degree in men. Furthermore, men do not have a better overall breast cancer prognosis compared with women, after adjustments have been made for age and tumor stage. While the androgen receptor content has been assessed in a few studies, there are no studies on the estrogen receptor-β content of breast tumors in men.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. R. W. Crichlow and S. W. Galt (1990). Male breast cancer. Surg. Clin. North Am. 70(5):1165–1177.

    Google Scholar 

  2. H. Olsson (1990). Reproductive and hormonal factors in relation to cancer occurrence in the breast, cervix and corpus uteri, testis, prostate and the thyroid gland. In B. Nordenskjöld, A. Macieira-Coelho, (eds.), Cancer and Aging, CRC Press Boca Raton, Florida pp. 109–126.

    Google Scholar 

  3. P. P. Rosen, C. J. Menendez-Botet, J. S. Nisselbaum, M. K. Schwartz, and J. A. Urban (1976). Estrogen receptor protein in lesions of the male breast. A preliminary report. Cancer 37:1866–1868.

    Google Scholar 

  4. Y. Nomura, H. Kondo, J. Yamagata, and K. Takenaka (1977). Detection of the estrogen receptor and response to endocrine therapy in male breast cancer patients. Gann 68:333–336.

    Google Scholar 

  5. M. J. Duffy and G. J. Duffy (1978). Multiple steroid receptors in male breast carcinomas. Clin. Chim. Acta 85(2):211–214.

    Google Scholar 

  6. N. Gupta, J. L. Cohen, C. Rosenbaum, and S. Raam (1980). Estrogen receptors in male breast cancer. Cancer 46(8):1781–1784.

    Google Scholar 

  7. R. B. Everson, M. E. Lippman, E. B. Thompson, W. L. McGuire, J. L. Wittliff, E. R. De Sombre, E. V. Jensen, A. Singhakowinta, S. C. Brooks, Jr., and J. P. Neifeld (1980). Clinical correlations of steroid receptors and male breast cancer. Cancer Res. 40(4):991–997.

    Google Scholar 

  8. H. S. Ellison, S. A. Scheuer, and E. R. Eichner (1980). Metastatic breast carcinoma with positive estrogen and progesterone receptors in a man with Klinefelter's syndrome. South Med. J. 73(10):1393–1396.

    Google Scholar 

  9. C. Silfverswärd, J-Å. Gustafsson, S. A. Gustafsson, S. Humla, B. Nordenskjöld, A. Wallgren, and Ö. Wrange (1980). Estrogen receptor concentrations in 269 cases of histologically classified human breast cancer. Cancer 45:2001–2005.

    Google Scholar 

  10. S. J. Ruff, J. E. Bauer, E. J. Keenan, H. S. Moseley, and W. S. Fletcher (1981). Hormone receptors in male breast carcinoma. J. Surg. Oncol. 18(1):55–59.

    Google Scholar 

  11. M. A. Friedman, P. G. Hoffman, Jr., E. M. Dandolos, M. D. Lagios, W. H. Johnston, and P. K. Siiteri (1981). Estrogen receptors in male breast cancer: Clinical and pathologic correlations. Cancer 47(1):134–137.

    Google Scholar 

  12. R. J. Pegoraro, D. Nirmul, and S. M. Joubert (1982). Cytoplasmic and nuclear estrogen and progesterone receptors in male breast cancer. Cancer Res. 42(11):4812–4814.

    Google Scholar 

  13. R. J. Mercer, R. M. Bryan, and R. C. Bennett (1984). Hormone receptors in male breast cancer. Aust. N. Z. J. Surg. 54(3):215–218.

    Google Scholar 

  14. M. M. Pacheco, C. F. Oshima, M. P. Lopes, A. Widman, E. L. Franco, and M. M. Brentani (1986). Steroid hormone receptors in male breast diseases. Anticancer Res. 6(5):1013–1017.

    Google Scholar 

  15. R. N. Xu (1989). [Male breast cancer: Clinical, pathologic and immunohistochemical study]. Chung Hua Wai Ko Tsa Chih 27(1):28–30, 61.

    Google Scholar 

  16. Z. Sulyok and I. Koves (1993). Male breast tumors. Eur. J. of Surg. Oncol. 19(6):581–586.

    Google Scholar 

  17. H. Stalsberg, D. B. Thomas, K. A. Rosenblatt, L. M. Jimenez, A. McTiernan, A. Stemhagen, W. D. Thompson, M. G. McCrea Curnen, W. Satariano, D. F. Austin, R. S. Greenberg, C. Key, L. Kolonel, and D. West (1993). Histologic types and hormone receptors in breast cancer in men: A populationbased study in 282 U.S. men. Cancer Causes Control 4(2):143–151.

    Google Scholar 

  18. K. Weber-Chappuis, S. Bieri-Burger, and J. Hurlimann (1996). Comparison of prognostic markers detected by immunohistochemistry in male and female breast carcinomas. Eur. J. Cancer 32A(10):1686–1692.

    Google Scholar 

  19. W. L. Williams, Jr., M. Powers, and L. D. Wagman (1996). Cancer of the male breast: A reviw. J. Natl. Med. Assoc. 88(7):439–443.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Olsson, H. Estrogen Receptor Content in Malignant Breast Tumors in Men—a Review. J Mammary Gland Biol Neoplasia 5, 283–287 (2000). https://doi.org/10.1023/A:1009546811429

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1009546811429

Navigation